By Barbara Stephenson Posted April 18, 2020 InMelanoma2020-04-182021-03-03https://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.pngCofactor Genomicshttps://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.png200px200px MelanomaRecent PostsCofactor Genomics Commences First Predictive Immune Modeling Clinical Trial to Bridge Precision Medicine Gap for ImmunotherapyMultidimensional Predictive Diagnostics: The GPS of Clinical PracticeCofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data BuildsNew Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer